Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins
July 17, 2024 07:00 ET
|
Draupnir Bio
Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins MP Healthcare and EIFO join existing investors, Gilde Healthcare...
Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease
September 23, 2021 07:00 ET
|
Draupnir Bio
Press Release Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease Copenhagen, Denmark, 23 September 2021 – Draupnir Bio...
Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease
September 23, 2021 02:00 ET
|
Draupnir Bio
Press Release Draupnir Bio establishes Scientific Advisory Board of European experts in cholesterol metabolism and cardiovascular disease Copenhagen, Denmark, 23 September 2021 – Draupnir Bio...
Draupnir Bio strengthens senior management with the appointment of Anna Quattropani as Chief Discovery Officer
July 12, 2021 07:00 ET
|
Draupnir Bio
Press Release Draupnir Bio strengthens senior management with the appointment of Anna Quattropani as Chief Discovery Officer Copenhagen, Denmark, 12 July 2021 – Draupnir Bio (“Draupnir”), a...
Draupnir Bio strengthens senior management with the appointment of Anna Quattropani as Chief Discovery Officer
July 12, 2021 02:00 ET
|
Draupnir Bio
Press Release Draupnir Bio strengthens senior management with the appointment of Anna Quattropani as Chief Discovery Officer Copenhagen, Denmark, 12 July 2021 – Draupnir Bio (“Draupnir”), a...
Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer
June 23, 2021 07:00 ET
|
Draupnir Bio
Press Release Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer Copenhagen and Aarhus, Denmark, 23 June 2021 – Draupnir Bio (“Draupnir”), a biotechnology company developing small...
Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer
June 23, 2021 02:00 ET
|
Draupnir Bio
Press Release Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer Copenhagen and Aarhus, Denmark, 23 June 2021 – Draupnir Bio (“Draupnir”), a biotechnology company developing small...